COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH:
Working… Menu

Bone Resorption, Osteoclastogenesis and Adalimumab (BROCAII)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02035800
Recruitment Status : Unknown
Verified May 2018 by Université de Sherbrooke.
Recruitment status was:  Recruiting
First Posted : January 14, 2014
Last Update Posted : May 8, 2018
Information provided by (Responsible Party):
Université de Sherbrooke

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : December 2018
Estimated Study Completion Date : December 2019